Assessment included chest computed tomography imaging to evaluate structural changes in the lungs due to treatment.
Findings highlight the potential for achieving clinical remission in severe asthma patients with tezepelumab, though larger trials are warranted.
Resumen
In summary, tezepelumab induced significant benefits in patients with severe asthma in this real-world cohort, improving symptoms, lung function, and radiological outcomes.